Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Tempest Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 24 | 18 | −6 |
| SharesConverted for a 1-for-13 split | 460.6K | 944.6K | +484.0K (+105.1%) |
| Value | $4.42M | $6.42M | +$2.00M (+45.4%) |
New holders (3)
Institutions that held Tempest Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 276,587 | $1.88M | 14.47% |
| Tang Capital Management LLC | 138,962 | $944.9K | 0.05% |
| Raymond James Financial Inc | 234 | $1.59K | 0.00% |
Sold out (9)
Institutions that held Tempest Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Susquehanna International Group, LLP | 114,559 | $84.5K |
| Northern Trust Corp | 99,391 | $73.4K |
| Davenport & Co LLC | 50,000 | $36.9K |
| State Street Corp | 41,492 | $30.6K |
| Simplex Trading, LLC | 20,422 | $15.0K |
| MayTech Global Investments, LLC | 10,000 | $7.38K |
| Millstone Evans Group, LLC | 800 | $590 |
| JPMorgan Chase & Co | 77 | $57 |
| Royal Bank of Canada | 1 | $0 |